The incidence of brain metastasis in patients with metastatic breast cancer varies from 10 to 15% [2] and these rates are as high as 50% in patients with the Erb-B2 receptor tyrosine kinase 2 (ERBB2 or HER2)-positive breast cancer [3]. Here, ERBB2 is linked to breast cancer.